4
Changes in Ownership
Protalix BioTherapeutics, Inc. Filed Acc 0001144204-19-045806
Options or other derivatives
- Sr. VP & CFO acquired 800,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Rubin Eyal Sr. VP & CFO | 2019-09-22 | Grant or award · Stock Options (Right to Buy) | +800,000 | 800,000 | D | ||
Loading xslF345X03/tv530009_4.xml…